Organon’s Asenapine Effective in a Phase III Study for the Treatment …
Forbes - SAN DIEGO, May 21 /PRNewswire/ — Asenapine — an investigational drug being developed by Organon, the human healthcare business unit of Akzo Nobel, for bipolar I disorder and schizophrenia — was demonstrated to be more effective than placebo in …